A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Phenyl Amide Compounds and Methods of Use
Assignee: Schrödinger, Inc.Publication Number: US 20250368634 A1Filed: June 13, 2023Publication Date: December 4, 2025Inventors: Jeremy Greenwood, Evelyne Houang, Zef Konst, Abba Leffler, Adam Levinson, Andrew Placzek, Anatoly Ruvinsky What This Covers This patent application discloses novel phenyl amide compounds (of a…
-
Compositions and Methods for Treating Anemia (Vadadustat)
Assignee: Akebia Therapeutics, Inc. (and/or its licensors)Patent Number: US 11,844,756 B2Filing Date: (Derived from family; issued in prior years and active through 2025)Title: Compositions and Methods for Treating AnemiaStatus in 2025: Active/Enforced patent protecting vadadustat‑based therapies What…
-
Cellular Reprogramming and Transdifferentiation: Engineering Cell Identity and the Legal Status of Artificial Lineages
Cell engineering has progressed from modifying cellular function to redefining cellular identity itself. Through cellular reprogramming and transdifferentiation, differentiated cells can be converted into pluripotent stem cells or directly into other specialized cell types. These…
BioTech IP Review 